| Year |
Citation |
Score |
| 2011 |
Nagy B, Jin J, Ashby B, Reilly MP, Kunapuli SP. Contribution of the P2Y12 receptor-mediated pathway to platelet hyperreactivity in hypercholesterolemia. Journal of Thrombosis and Haemostasis : Jth. 9: 810-9. PMID 21261805 DOI: 10.1111/J.1538-7836.2011.04217.X |
0.36 |
|
| 2010 |
Mao Y, Zhang L, Jin J, Ashby B, Kunapuli SP. Mutational analysis of residues important for ligand interaction with the human P2Y(12) receptor. European Journal of Pharmacology. 644: 10-6. PMID 20599922 DOI: 10.1016/J.Ejphar.2010.06.023 |
0.58 |
|
| 2004 |
Bilson HA, Mitchell DL, Ashby B. Human prostaglandin EP3 receptor isoforms show different agonist-induced internalization patterns. Febs Letters. 572: 271-5. PMID 15304361 DOI: 10.1016/J.Febslet.2004.06.089 |
0.42 |
|
| 2002 |
Ozdener F, Dangelmaier C, Ashby B, Kunapuli SP, Daniel JL. Activation of phospholipase Cgamma2 by tyrosine phosphorylation. Molecular Pharmacology. 62: 672-9. PMID 12181444 DOI: 10.1124/Mol.62.3.672 |
0.309 |
|
| 2001 |
Sakolsky DJ, Ashby B. Patterns of cyclic AMP formation by coexpressed D1 and D2L dopamine receptors in HEK 293 cells. Receptors & Channels. 7: 479-89. PMID 11918350 |
0.667 |
|
| 2001 |
Desai S, Ashby B. Agonist-induced internalization and mitogen-activated protein kinase activation of the human prostaglandin EP4 receptor. Febs Letters. 501: 156-60. PMID 11470276 DOI: 10.1016/S0014-5793(01)02640-0 |
0.713 |
|
| 2000 |
Sakolsky DJ, Ashby B. Determination of D1 and D2 dopamine receptor expression by Ntera-2 cells. Brain Research. Molecular Brain Research. 84: 158-61. PMID 11113544 DOI: 10.1016/S0169-328X(00)00239-4 |
0.641 |
|
| 2000 |
Desai S, April H, Nwaneshiudu C, Ashby B. Comparison of agonist-induced internalization of the human EP2 and EP4 prostaglandin receptors: role of the carboxyl terminus in EP4 receptor sequestration. Molecular Pharmacology. 58: 1279-86. PMID 11093764 DOI: 10.1124/Mol.58.6.1279 |
0.683 |
|
| 2000 |
Xin L, Geller EB, Bastepe M, Raffa RB, Mao GF, Ashby B, Adler MW. Suppression of fever and hyperalgesic responses to the EP3-receptor agonist GR 63799X by EP3-receptor antisense in rats Journal of Thermal Biology. 25: 77-79. DOI: 10.1016/S0306-4565(99)00093-5 |
0.523 |
|
| 1999 |
Bastepe M, Ashby B. Identification of a region of the C-terminal domain involved in short-term desensitization of the prostaglandin EP4 receptor. British Journal of Pharmacology. 126: 365-71. PMID 10051157 DOI: 10.1038/Sj.Bjp.0702291 |
0.54 |
|
| 1998 |
Paul BZ, Ashby B, Sheth SB. Distribution of prostaglandin IP and EP receptor subtypes and isoforms in platelets and human umbilical artery smooth muscle cells. British Journal of Haematology. 102: 1204-11. PMID 9753046 DOI: 10.1046/j.1365-2141.1998.00910.x |
0.412 |
|
| 1998 |
Ashby B. Co-expression of prostaglandin receptors with opposite effects: a model for homeostatic control of autocrine and paracrine signaling. Biochemical Pharmacology. 55: 239-46. PMID 9484788 DOI: 10.1016/S0006-2952(97)00241-4 |
0.533 |
|
| 1998 |
Daniel JL, Dangelmaier C, Jin J, Ashby B, Smith JB, Kunapuli SP. Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets. The Journal of Biological Chemistry. 273: 2024-9. PMID 9442039 DOI: 10.1074/Jbc.273.4.2024 |
0.477 |
|
| 1997 |
Ortiz-Vega S, Ashby B. Human prostacyclin receptor: cloning and co-expression with EP3 prostaglandin receptor. Advances in Experimental Medicine and Biology. 433: 235-8. PMID 9561143 DOI: 10.1007/978-1-4899-1810-9_50 |
0.463 |
|
| 1997 |
Bastepe M, Ashby B. The long cytoplasmic carboxyl terminus of the prostaglandin E2 receptor EP4 subtype is essential for agonist-induced desensitization. Molecular Pharmacology. 51: 343-9. PMID 9203641 DOI: 10.1124/Mol.51.2.343 |
0.593 |
|
| 1997 |
Jin J, Mao GF, Ashby B. Constitutive activity of human prostaglandin E receptor EP3 isoforms. British Journal of Pharmacology. 121: 317-23. PMID 9154343 DOI: 10.1038/Sj.Bjp.0701121 |
0.554 |
|
| 1996 |
Mao GF, Jin JG, Bastepe M, Ortiz-Vega S, Ashby B. Prostaglandin E2 both stimulates and inhibits adenyl cyclase on platelets: comparison of effects on cloned EP4 and EP3 prostaglandin receptor subtypes. Prostaglandins. 52: 175-85. PMID 8908618 DOI: 10.1016/S0090-6980(96)00095-0 |
0.506 |
|
| 1996 |
Akbar GK, Dasari VR, Sheth SB, Ashby B, Mills DC, Kunapuli SP. Characterization of P2 purinergic receptors on human erythro leukemia cells. Journal of Receptor and Signal Transduction Research. 16: 209-24. PMID 8897312 DOI: 10.3109/10799899609039949 |
0.533 |
|
| 1996 |
Akbar GK, Dasari VR, Webb TE, Ayyanathan K, Pillarisetti K, Sandhu AK, Athwal RS, Daniel JL, Ashby B, Barnard EA, Kunapuli SP. Molecular cloning of a novel P2 purinoceptor from human erythroleukemia cells. The Journal of Biological Chemistry. 271: 18363-7. PMID 8702478 DOI: 10.1074/Jbc.271.31.18363 |
0.493 |
|
| 1995 |
Pulcinelli FM, Ashby B, Gazzaniga PP, Daniel JL. Protein kinase C activation is not a key step in ADP-mediated exposure of fibrinogen receptors on human platelets. Febs Letters. 364: 87-90. PMID 7772199 DOI: 10.1016/0014-5793(95)00352-A |
0.316 |
|
| 1994 |
Kunapuli SP, Fen Mao G, Bastepe M, Liu-Chen LY, Li S, Cheung PP, DeRiel JK, Ashby B. Cloning and expression of a prostaglandin E receptor EP3 subtype from human erythroleukaemia cells. The Biochemical Journal. 298: 263-7. PMID 8135729 DOI: 10.1042/Bj2980263 |
0.57 |
|
| 1994 |
Ashby B. Interactions among prostaglandin receptors. Receptor. 4: 31-42. PMID 8038705 |
0.487 |
|
| 1994 |
Li S, Zhu J, Chen C, Chen YW, Smyth RJ, Sakolsky DJ, Sheng S, Cao W, deRiel JK, Ashby B, Liu-Chen LY. Cloning and expression of a rat opioid receptor with κ characteristics Regulatory Peptides. 53: S11-S12. DOI: 10.1016/0167-0115(94)90216-X |
0.634 |
|
| 1993 |
Li S, Zhu J, Chen C, Chen YW, Deriel JK, Ashby B, Liu-Chen LY. Molecular cloning and expression of a rat kappa opioid receptor. The Biochemical Journal. 295: 629-33. PMID 8240268 DOI: 10.1042/Bj2950629 |
0.46 |
|
| 1992 |
Ashby B. Comparison of Iloprost, Cicaprost and prostacyclin effects on cyclic AMP metabolism in intact platelets. Prostaglandins. 43: 255-61. PMID 1378640 DOI: 10.1016/0090-6980(92)90093-9 |
0.441 |
|
| 1992 |
Smith JB, Dangelmaier C, Selak MA, Ashby B, Daniel J. Cyclic AMP does not inhibit collagen-induced platelet signal transduction. The Biochemical Journal. 283: 889-92. PMID 1375452 DOI: 10.1042/Bj2830889 |
0.306 |
|
| 1991 |
Ashby B, Almonor GO, Wernick E, Selak MA. Prostaglandin-concentration-dependent desensitization of adenylate cyclase in human erythroleukaemia (HEL) cells is abolished by pertussis toxin and enhanced by induction by dimethyl sulphoxide. The Biochemical Journal. 280: 801-4. PMID 1722394 DOI: 10.1042/Bj2800801 |
0.455 |
|
| 1990 |
Williams JA, Ashby B, Daniel JL. Ligands to the platelet fibrinogen receptor glycoprotein IIb-IIIa do not affect agonist-induced second messengers Ca2+ or cyclic AMP. The Biochemical Journal. 270: 149-55. PMID 2168700 DOI: 10.1042/Bj2700149 |
0.351 |
|
| 1990 |
Ashby B. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets. Molecular Pharmacology. 38: 46-53. PMID 1695318 |
0.451 |
|
| 1989 |
Ashby B. Model of prostaglandin-regulated cyclic AMP metabolism in intact platelets: examination of time-dependent effects on adenylate cyclase and phosphodiesterase activities. Molecular Pharmacology. 36: 866-73. PMID 2481225 |
0.338 |
|
| 1988 |
Ashby B. Cyclic AMP turnover in response to prostaglandins in intact platelets: evidence for separate stimulatory and inhibitory prostaglandin receptors. Second Messengers and Phosphoproteins. 12: 45-57. PMID 2848122 |
0.314 |
|
| Show low-probability matches. |